last authored: August 2011, David LaPierre
last reviewed:
Alcohol withdrawal syndrome (AWS) is a set of symptoms that results from an abrupt discontinuance of alcohol in someone who is dependent on it. It is likely to occur if alcohol is consumed in large quantities for a period of greater than two weaks, and then is abruptly discontinued.
Alcohol affects the central nervous system, including the autonomic nervous system and cognitive function.
Symptoms, which can begin within 5 hours and last for days, can range from mild to fatal.
Alcohol withdrawal occurs in a series of stages.
Stage I: 5-8 hours
|
Stage II: 24-72 hours
|
Stage III: 72-96 hours
|
John is a 46 year-old man who comes to the emergency department with chest pain. He describes a fall 2 days ago that took place when he was very drunk. He has not had a drink since, and has been feeling very shakey. Your investigations reveal a rib fracture. You decide to admit him for alcohol withdrawal.
Risk factors for the development of alcohol withdrawal syndrome include:
Alcohol acts on the inhibitory GABA receptors in the brain. With extended use, GABA receptors are downregulated. At the same time, inhibition of glutamate signaling by alcohol results in upregulation of excitatory NMDA receptors.
Abrupt cessation of alcohol leaves the brain in a hyper-excitable state due to downregulation of inhibitory GABA and upregulation of excitatory NMDA.
Delerium tremens represents a hyperadrenergic state with multiple abnormalities of autonomic factors: pulse, blood pressure, temperature, respiratory rate, and diaphoresis. Cognitive changes also occur, including impaired attention, disorientation, and hallucinations.
Diagnosis is likely if two or more of the following symptoms are present:
Important details to ask about include:
On exam, evaluate for:
Validated tools should be done to assess for severity of AWS. The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) is often used (outside link)
CBC: macrocytosis, pancytopenia
electrolytes
renal function tests
glucose
TSH
liver enzymes
magnesium
blood alcohol level
microbiology: blood C&S, urinalysis, urine C&S
ECG
consider chest X-ray, CT head
The differential diagnosis includes:
The goal of treatment of AWS is to reduce symptoms, as well as the chances of DTs, and death. It is also helpful to support long-term abstinence. Symptoms normally subside within one week.
Mild or moderate AWS may be treated as an outpatient, as it is normally safe, effective, and less expensive than inpatient care. However, if serious psychiatric or medical conditions are present, inpatient withdrawal management is likely preferable (Muncie, Yasinian, and Oge, 2013). Outpatient care should not be used if drug abuse is also present, and should include close contact with trusted friends or family, as well as primary care. Community support should be ensured.
Daily monitoring is normal until symptoms and medication use are reduced; once this occurs and alcohol intake has stopped for at least three days, it is recommended to enroll a patient in a long0term treatment program.
Acute treatment involves ABCs:
Benzodiazepines such as lorazepam, diazepam, oxazepam, or chlordiazepoxide are used most commonly to reduce symptoms of AWS and prevent the onset of seizures. They may be used in fixed- or symptom-specific dosing. The former is easier to use in an outpatient setting, as it requires less scoring (eg, with the CIWA-Ar or SAWS tools). As-needed medications may also be used.
Anticonvulsants such as carbamazepine, gabapentin, oxcarbazepine, or valproic acid may also be used, but with more troubling adverse effects (eg dizziness, nausea, vomiting).
Clonidine or beta-blockers (especially atenolol) can be used to control authonomic instability.
Nutritional and vitamin support should include thiamine (100mg daily), which should be given before glucose, as well as folic acid (1mg daily).
Counselling should be offered once stabilized.
Alcohol withdrawal can be life-threatening.
Muncie HL, Yasinian Y, Oge', Linda. 2013. Outpatient management of alcohol withdrawal syndrome. AFP. 88(9):589-595.
authors:
reviewers: